Amen side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Amen. Common side effects include acute respiratory failure among females and renal failure acute among males.

The phase IV clinical study is created by eHealthMe based on 93 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 18, 2022

93 people who take Amen and have side effects are studied.


What is Amen?

Amen has active ingredients of medroxyprogesterone acetate. eHealthMe is studying from 96 Amen users for its effectiveness, alternative drugs and more.

Number of Amen reports submitted per year:

Amen side effects.

Amen side effects by time on the drug*:

< 1 month:

  1. Pulmonary embolism (blockage of the main artery of the lung)

1 - 6 months:

  1. Pulmonary embolism (blockage of the main artery of the lung)

6 - 12 months:

n/a

1 - 2 years:

  1. Breast cancer

2 - 5 years:

  1. Vulvovaginal burning sensation
  2. Breast cancer female
  3. Breast cancer
  4. Aortic valve disease
  5. Atrophic vulvovaginitis (inflammation of the vulva)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Pulmonary embolism (blockage of the main artery of the lung)

5 - 10 years:

  1. Breast cancer female
  2. Breast cancer

10+ years:

  1. Breast cancer female
  2. Breast cancer

not specified:

  1. Breast cancer
  2. Breast cancer female
  3. Breast cancer metastatic
  4. Ovarian cancer (cancer of ovary)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Ovarian cancer metastatic (cancer of ovary spreads to other organ or parts)
  7. Activities of daily living impaired
  8. Acute respiratory failure
  9. Anaemia (lack of blood)
  10. Blood cholesterol increased

Amen side effects by gender *:

female:

  1. Acute respiratory failure
  2. Aortic valve disease
  3. Blood cholesterol increased
  4. Breast cancer recurrent
  5. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Feeling abnormal
  8. Hepatic necrosis (large portions of liver die off due to severe liver disease)
  9. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  10. Swelling

male:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Anaemia (lack of blood)
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

Amen side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Renal failure acute (rapid kidney dysfunction)

40-49:

  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Hepatic necrosis (large portions of liver die off due to severe liver disease)

50-59:

  1. Breast cancer
  2. Breast cancer female
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Breast cancer metastatic
  5. Ovarian cancer metastatic (cancer of ovary spreads to other organ or parts)
  6. Blood cholesterol increased
  7. Breast cancer recurrent
  8. Feeling abnormal
  9. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  10. Swelling

60+:

  1. Activities of daily living impaired
  2. Aortic valve disease
  3. Breast cancer female
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Breast cancer
  6. Pulmonary embolism (blockage of the main artery of the lung)

* Approximation only. Some reports may have incomplete information.

Do you take Amen?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

How the study uses the data?

The study is based on medroxyprogesterone acetate (the active ingredients of Amen) and Amen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Amen:

All Amen side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: